
What’s Your Synthetic Biology Strategy?
By analyzing the syn-bio industry stack and understanding its dynamics, incumbents can develop strategies that will gain them competitive advantage.
Almost anything can be created through synthetic biology, and BCG helps clients harness syn-bio capabilities to drive winning strategies in a range of verticals, from food and pharma to clothing and construction.
To many industries, synthetic biology means disruption—but also opportunity. Our synthetic biology consultants help companies understand both how syn-bio can transform their sector and where they can deploy syn-bio technologies in order to achieve lower production costs and greater profits.
Synthetic biology is an emerging technology centered on science and engineering to create materials that enable innovative, sustainable, resilient, low-cost manufacturing and product development. It draws on nature to create new biological components and systems—or improve existing ones—such as alternative proteins, programmed cells, and gene modification.
BCG helps clients develop a syn-bio strategy through an extensive approach:
By analyzing the syn-bio industry stack and understanding its dynamics, incumbents can develop strategies that will gain them competitive advantage.
Synthetic biology is a difficult technology to master and especially tough to scale. Chemical and materials startups and their backers need to find the meeting place of technology capability, market need, and cost.
Synthetic biology technologies are finally maturing, becoming the way almost anything can be manufactured competitively and sustainably. Businesses must learn to use syn-bio to develop new products and processes, improve existing ones, and reduce costs to remain competitive in the future.
A new wave of innovation is coming. Pharma companies need to determine the role they will play in shaping it.
Our synthetic biology consultants are experts in the complexities of deep tech and using emerging technologies to solve large issues. They are positioned to support clients engaging syn-bio as a potential business opportunity or implementing synthetic biology into workflows and strategy. Here are some of our experts on the topic: